News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Eli Lilly and Company Says Judge Prevents Launch of Generic Evista
April 23, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LOS ANGELES, April 22 (Reuters) - Eli Lilly and Co (LLY.N) said on Wednesday that a federal judge issued a preliminary injunction preventing the launch of a generic version of osteoporosis drug Evista.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Eli Lilly and Company
MORE ON THIS TOPIC
Obesity
WHO Leaning Toward Adding Obesity Drugs for Adults to Essential Medicines List:
Reuters
May 2, 2025
·
2 min read
·
Tristan Manalac
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
May 1, 2025
·
3 min read
·
Heather McKenzie
Earnings
Pfizer CEO Calls Trump’s Pharma National Security Concerns ‘Legitimate’
April 29, 2025
·
3 min read
·
Annalee Armstrong
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
April 29, 2025
·
2 min read
·
Tristan Manalac
